Study: Treatment-resistant childhood leukemia tied to gene

01/12/2009 | Yahoo!

Dutch and German researchers found that children with a subtype of acute lymphoblastic leukemia who have the BCR-ABL1 fusion gene are more prone to relapse than patients without the gene. The finding suggests that carriers of the gene should get more intensive treatment with medicines already on the market "or with new, more-targeted drugs for which the biology of the BCR-ABL1-like subtype needs further study," the lead scientist said.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX